BridgeBio Pharma Terminates Merger Process With Its Subsidiary Eidos Therapeutics

Monday, October 14, 2019 1 min read

Key Takeaway: BridgeBio Pharma Terminates Merger Process With Its Subsidiary Eidos Therapeutics

Full Press Release Details

BridgeBio Pharma Terminates Merger Process With Its Subsidiary Eidos Therapeutics.